title: [Molecular mechanisms of lenalidomide for the treatment of myelodysplastic syndromes].
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Katayama
mesh_terms: D000748:Anemia, Macrocytic / Q000188:drug therapy* / Q000235:genetics*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D016158:Genes, p53; D006238:Haploidy; D006801:Humans; D000077269:Lenalidomide; D035683:MicroRNAs; D058990:Molecular Targeted Therapy; D009190:Myelodysplastic Syndromes; D012269:Ribosomal Proteins / Q000235:genetics; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; C541010:MIRN145 microRNA, human; C542542:MIRN146 microRNA, human; D035683:MicroRNAs; C526722:RPS14 protein, human; D012269:Ribosomal Proteins; D013792:Thalidomide; D000077269:Lenalidomide